Cargando…
Hyperinsulinemia and insulin resistance in the obese may develop as part of a homeostatic response to elevated free fatty acids: A mechanistic case-control and a population-based cohort study
BACKGROUND: It is commonly accepted that in obesity free fatty acids (FFA) cause insulin resistance and hyperglycemia, which drives hyperinsulinemia. However, hyperinsulinemia is observed in subjects with normoglycaemia and thus the paradigm above should be reevaluated. METHODS: We describe two stud...
Autores principales: | Fryk, Emanuel, Olausson, Josefin, Mossberg, Karin, Strindberg, Lena, Schmelz, Martin, Brogren, Helén, Gan, Li-Ming, Piazza, Silvano, Provenzani, Alessandro, Becattini, Barbara, Lind, Lars, Solinas, Giovanni, Jansson, Per-Anders |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7992078/ https://www.ncbi.nlm.nih.gov/pubmed/33712379 http://dx.doi.org/10.1016/j.ebiom.2021.103264 |
Ejemplares similares
-
The role of the platelet pool of Plasminogen Activator Inhibitor-1 in well-controlled type 2 diabetes patients
por: Mossberg, Karin, et al.
Publicado: (2022) -
Feasibility of high-dose tadalafil and effects on insulin resistance in well-controlled patients with type 2 diabetes (MAKROTAD): a single-centre, double-blind, randomised, placebo-controlled, cross-over phase 2 trial
por: Fryk, Emanuel, et al.
Publicado: (2023) -
Galectin-1 is inversely associated with type 2 diabetes independently of obesity – A SCAPIS pilot study()
por: Fryk, Emanuel, et al.
Publicado: (2019) -
The role of circulating galectin-1 in type 2 diabetes and chronic kidney disease: evidence from cross-sectional, longitudinal and Mendelian randomisation analyses
por: Drake, Isabel, et al.
Publicado: (2021) -
Galectin-1 in Obesity and Type 2 Diabetes
por: Fryk, Emanuel, et al.
Publicado: (2022)